378 related articles for article (PubMed ID: 28038954)
1. Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA.
Kulkarni JA; Myhre JL; Chen S; Tam YYC; Danescu A; Richman JM; Cullis PR
Nanomedicine; 2017 May; 13(4):1377-1387. PubMed ID: 28038954
[TBL] [Abstract][Full Text] [Related]
2.
Algarni A; Pilkington EH; Suys EJA; Al-Wassiti H; Pouton CW; Truong NP
Biomater Sci; 2022 May; 10(11):2940-2952. PubMed ID: 35475455
[TBL] [Abstract][Full Text] [Related]
3. Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles.
Yanez Arteta M; Kjellman T; Bartesaghi S; Wallin S; Wu X; Kvist AJ; Dabkowska A; Székely N; Radulescu A; Bergenholtz J; Lindfors L
Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3351-E3360. PubMed ID: 29588418
[TBL] [Abstract][Full Text] [Related]
4. Lipid nanoparticle siRNA systems for silencing the androgen receptor in human prostate cancer in vivo.
Lee JB; Zhang K; Tam YY; Tam YK; Belliveau NM; Sung VY; Lin PJ; LeBlanc E; Ciufolini MA; Rennie PS; Cullis PR
Int J Cancer; 2012 Sep; 131(5):E781-90. PubMed ID: 22095615
[TBL] [Abstract][Full Text] [Related]
5. Intracellular trafficking kinetics of nucleic acid escape from lipid nanoparticles via fluorescence imaging.
M Bailey-Hytholt C; Ulinski G; Dugas J; Haines M; Lazebnik M; Piepenhagen P; E Zarraga I; Bandekar A
Curr Pharm Biotechnol; 2023 Apr; ():. PubMed ID: 37016519
[TBL] [Abstract][Full Text] [Related]
6. Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells.
Ferraresso F; Strilchuk AW; Juang LJ; Poole LG; Luyendyk JP; Kastrup CJ
Mol Pharm; 2022 Jul; 19(7):2175-2182. PubMed ID: 35642083
[TBL] [Abstract][Full Text] [Related]
7. pH-dependent structural transitions in cationic ionizable lipid mesophases are critical for lipid nanoparticle function.
Philipp J; Dabkowska A; Reiser A; Frank K; Krzysztoń R; Brummer C; Nickel B; Blanchet CE; Sudarsan A; Ibrahim M; Johansson S; Skantze P; Skantze U; Östman S; Johansson M; Henderson N; Elvevold K; Smedsrød B; Schwierz N; Lindfors L; Rädler JO
Proc Natl Acad Sci U S A; 2023 Dec; 120(50):e2310491120. PubMed ID: 38055742
[TBL] [Abstract][Full Text] [Related]
8. Transfection of plasmid DNA by nanocarriers containing a gemini cationic lipid with an aromatic spacer or its monomeric counterpart.
Martínez-Negro M; Barrán-Berdón AL; Aicart-Ramos C; Moyá ML; de Ilarduya CT; Aicart E; Junquera E
Colloids Surf B Biointerfaces; 2018 Jan; 161():519-527. PubMed ID: 29128838
[TBL] [Abstract][Full Text] [Related]
9. Engineered ionizable lipid siRNA conjugates enhance endosomal escape but induce toxicity in vivo.
Biscans A; Ly S; McHugh N; Cooper DA; Khvorova A
J Control Release; 2022 Sep; 349():831-843. PubMed ID: 35917865
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluation of clinically-approved ionizable cationic lipids shows divergent results between mRNA transfection and vaccine efficacy.
Escalona-Rayo O; Zeng Y; Knol RA; Kock TJF; Aschmann D; Slütter B; Kros A
Biomed Pharmacother; 2023 Sep; 165():115065. PubMed ID: 37406506
[TBL] [Abstract][Full Text] [Related]
11. On the role of helper lipids in lipid nanoparticle formulations of siRNA.
Kulkarni JA; Witzigmann D; Leung J; Tam YYC; Cullis PR
Nanoscale; 2019 Nov; 11(45):21733-21739. PubMed ID: 31713568
[TBL] [Abstract][Full Text] [Related]
12. CHARMM-GUI Membrane Builder for Lipid Nanoparticles with Ionizable Cationic Lipids and PEGylated Lipids.
Park S; Choi YK; Kim S; Lee J; Im W
J Chem Inf Model; 2021 Oct; 61(10):5192-5202. PubMed ID: 34546048
[TBL] [Abstract][Full Text] [Related]
13. Ionizable amino lipid interactions with POPC: implications for lipid nanoparticle function.
Ramezanpour M; Schmidt ML; Bodnariuc I; Kulkarni JA; Leung SSW; Cullis PR; Thewalt JL; Tieleman DP
Nanoscale; 2019 Aug; 11(30):14141-14146. PubMed ID: 31334542
[TBL] [Abstract][Full Text] [Related]
14. DOPC
Ermilova I; Swenson J
Phys Chem Chem Phys; 2020 Dec; 22(48):28256-28268. PubMed ID: 33295352
[TBL] [Abstract][Full Text] [Related]
15. Flash nanoprecipitation assisted self-assembly of ionizable lipid nanoparticles for nucleic acid delivery.
Misra B; Hughes KA; Pentz WH; Samart P; Geldenhuys WJ; Bobbala S
Nanoscale; 2024 Apr; 16(14):6939-6948. PubMed ID: 38511623
[TBL] [Abstract][Full Text] [Related]
16. Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA.
Ball RL; Hajj KA; Vizelman J; Bajaj P; Whitehead KA
Nano Lett; 2018 Jun; 18(6):3814-3822. PubMed ID: 29694050
[TBL] [Abstract][Full Text] [Related]
17. Lipid-nucleic acid nanoparticles of novel ionizable lipids for systemic BMP-9 gene delivery to bone-marrow mesenchymal stem cells for osteoinduction.
Vhora I; Lalani R; Bhatt P; Patil S; Misra A
Int J Pharm; 2019 May; 563():324-336. PubMed ID: 30954673
[TBL] [Abstract][Full Text] [Related]
18. CHARMM-GUI Membrane Builder for Lipid Nanoparticles with Ionizable Cationic Lipids and PEGylated Lipids.
Park S; Choi YK; Kim S; Lee J; Im W
bioRxiv; 2021 Jun; ():. PubMed ID: 34189527
[TBL] [Abstract][Full Text] [Related]
19. Intravesical delivery of small activating RNA formulated into lipid nanoparticles inhibits orthotopic bladder tumor growth.
Kang MR; Yang G; Place RF; Charisse K; Epstein-Barash H; Manoharan M; Li LC
Cancer Res; 2012 Oct; 72(19):5069-79. PubMed ID: 22869584
[TBL] [Abstract][Full Text] [Related]
20. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
